Translational Pharmacokinetic/Pharmacodynamic Modeling of Tumor Growth Inhibition Supports Dose-Range Selection of the Anti-PD-1 Antibody Pembrolizumab.
about
Population Pharmacokinetic/Pharmacodynamic Modeling of Tumor Size Dynamics in Pembrolizumab-Treated Advanced Melanoma.Commentary on Pharmacometrics for Immunotherapy.Pembrolizumab: Role of Modeling and Simulation in Bringing a Novel Immunotherapy to Patients With Melanoma.Immuno-oncology Clinical Trial Design: Limitations, Challenges, and Opportunities.From Famine to Feast: Developing Early-Phase Combination Immunotherapy Trials Wisely.Pembrolizumab in the treatment of advanced urothelial cancer.Immune checkpoint inhibitors in advanced non-small cell lung cancer.Evolution of early phase clinical trials in oncology.KEYNOTE-010: flash of a supernova (immune-checkpoint inhibitors) in second-line non-small cell lung cancer.Quantitative translational modeling to facilitate preclinical to clinical efficacy & toxicity translation in oncology.Tumor molecular profiling of responders and non-responders following pembrolizumab monotherapy in chemotherapy resistant advanced cervical cancer.Pharmacometric Applications and Challenges in the Development of Therapeutic Antibodies in Immuno-Oncology
P2860
Q37609777-7938448A-6D26-45B7-935F-EA66E9E80DF7Q39082975-80C06F97-054D-4045-9A06-7C92F8F3AE17Q42327769-F40F58ED-1771-408F-AC70-4768795D9960Q45936626-3F79F4F5-B245-4182-9891-C111ECDBA832Q45952214-B785A554-0AE3-47C7-9F56-AFB8C4C444DAQ47345366-030B86B4-8FB6-4236-9BB8-6276B19FF890Q47563451-07BB22AE-CD91-4DDC-B364-208905A71057Q47816379-A6D7C18C-7F7D-4B2F-B3D1-F6C8B100FA69Q49217973-DA8C72F0-779C-43F8-A808-EFE00C9387E2Q55329667-9A6B9954-9218-4986-93CC-92B7FC1D5809Q55386599-19EF475A-148F-4BC3-9588-7A9D563E51DEQ57495826-5A524D6F-5C26-4B6F-AE06-140E21F89261
P2860
Translational Pharmacokinetic/Pharmacodynamic Modeling of Tumor Growth Inhibition Supports Dose-Range Selection of the Anti-PD-1 Antibody Pembrolizumab.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Translational Pharmacokinetic/ ...... i-PD-1 Antibody Pembrolizumab.
@en
Translational Pharmacokinetic/ ...... i-PD-1 Antibody Pembrolizumab.
@nl
type
label
Translational Pharmacokinetic/ ...... i-PD-1 Antibody Pembrolizumab.
@en
Translational Pharmacokinetic/ ...... i-PD-1 Antibody Pembrolizumab.
@nl
prefLabel
Translational Pharmacokinetic/ ...... i-PD-1 Antibody Pembrolizumab.
@en
Translational Pharmacokinetic/ ...... i-PD-1 Antibody Pembrolizumab.
@nl
P2093
P2860
P356
P1476
Translational Pharmacokinetic/ ...... i-PD-1 Antibody Pembrolizumab.
@en
P2093
A Lindauer
C R Valiathan
D P de Alwis
J Elassaiss-Schaap
R de Greef
P2860
P356
10.1002/PSP4.12130
P577
2016-11-08T00:00:00Z